DK471386D0 - Farmaceutisk komposition til behandling af leukopeni - Google Patents

Farmaceutisk komposition til behandling af leukopeni

Info

Publication number
DK471386D0
DK471386D0 DK471386A DK471386A DK471386D0 DK 471386 D0 DK471386 D0 DK 471386D0 DK 471386 A DK471386 A DK 471386A DK 471386 A DK471386 A DK 471386A DK 471386 D0 DK471386 D0 DK 471386D0
Authority
DK
Denmark
Prior art keywords
human
csf
leukopeni
treatment
pharmaceutical composition
Prior art date
Application number
DK471386A
Other languages
English (en)
Other versions
DK471386A (da
DK172204B1 (da
Inventor
Masahiko Tamura
Hitoshi Nomura
Kunihiro Hattori
Masayoshi Ono
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26462024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK471386(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DK471386D0 publication Critical patent/DK471386D0/da
Publication of DK471386A publication Critical patent/DK471386A/da
Application granted granted Critical
Publication of DK172204B1 publication Critical patent/DK172204B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK471386A 1985-10-04 1986-10-02 Farmaceutisk komposition indeholdende human granulocytkolonistimulerende faktor til behandling af leukopeni DK172204B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP22045085 1985-10-04
JP22045085 1985-10-04
JP12566086 1986-06-02
JP61125660A JPH0618778B2 (ja) 1985-10-04 1986-06-02 白血球減少症治療剤

Publications (3)

Publication Number Publication Date
DK471386D0 true DK471386D0 (da) 1986-10-02
DK471386A DK471386A (da) 1987-04-05
DK172204B1 DK172204B1 (da) 1998-01-05

Family

ID=26462024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK471386A DK172204B1 (da) 1985-10-04 1986-10-02 Farmaceutisk komposition indeholdende human granulocytkolonistimulerende faktor til behandling af leukopeni

Country Status (11)

Country Link
EP (1) EP0217404B2 (da)
JP (1) JPH0618778B2 (da)
KR (1) KR960000394B1 (da)
AT (1) ATE71662T1 (da)
AU (1) AU596997C (da)
DE (1) DE3683430D1 (da)
DK (1) DK172204B1 (da)
ES (1) ES2055684T5 (da)
FI (1) FI863971A7 (da)
HK (1) HK65693A (da)
NO (1) NO863918L (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3686582T2 (de) * 1985-11-27 1993-01-28 Genetics Inst Behandlung einer krankheit vom aids-typ.
JPH0618779B2 (ja) * 1986-01-22 1994-03-16 中外製薬株式会社 造血機能回復促進剤
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
CA1329119C (en) * 1988-03-29 1994-05-03 Milton David Goldenberg Cytotoxic therapy
US5178855A (en) * 1989-01-30 1993-01-12 Schering Corporation Treatment of luekocyte dysfunction with GM-CSF
EP0565722A1 (en) * 1990-12-25 1993-10-20 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical preparation for pernasal administration
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5686578A (en) 1994-08-05 1997-11-11 Immunomedics, Inc. Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
EP1274720A4 (en) 2000-04-12 2004-08-18 Human Genome Sciences Inc FUSION PROTEINS CONTAINING ALBUMIN
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
PT1463751E (pt) 2001-12-21 2013-08-26 Human Genome Sciences Inc Proteínas de fusão de albumina
SI21273A (sl) * 2002-07-31 2004-02-29 LEK farmacevtska dru�ba d.d. Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina
ES2403932T3 (es) 2002-08-27 2013-05-22 Biokine Therapeutics Ltd. Antagonista de CXCR4 y uso del mismo
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
KR100638453B1 (ko) * 2004-11-19 2006-10-24 씨제이 주식회사 포장용 박스 및 포장용 박스 접는방법
WO2008075370A2 (en) 2006-12-21 2008-06-26 Biokine Therapeutics Ltd. T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy
US9155780B2 (en) 2009-02-11 2015-10-13 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
US9427456B2 (en) 2009-06-14 2016-08-30 Biokine Therapeutics Ltd. Peptide therapy for increasing platelet levels
WO2013160895A1 (en) 2012-04-24 2013-10-31 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
EP3744340A3 (en) 2015-07-16 2021-03-03 Biokine Therapeutics Ltd. Compositions and methods for treating cancer
US10993985B2 (en) 2016-02-23 2021-05-04 BioLmeRx Ltd. Methods of treating acute myeloid leukemia
CN112175906B (zh) * 2019-07-05 2023-09-29 中国科学院生物物理研究所 胸腺嘧啶核苷诱导成纤维细胞转分化在中性粒细胞减少症治疗中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030295B2 (ja) * 1977-03-29 1985-07-16 森永乳業株式会社 白血球減少症治療剤の製造法
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
AU523077B2 (en) * 1978-03-20 1982-07-08 Green Cross Corporation, The Hgi glycoprotein
JPS5618591A (en) * 1979-07-20 1981-02-21 Morinaga Milk Ind Co Ltd Production of substance capable of differentiation and multiplication of stem cells of human granulocyte
JPS6030654B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒトコロニ−刺激因子の製造方法
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
JPS6181781A (ja) * 1984-09-28 1986-04-25 Morinaga Milk Ind Co Ltd 人顆粒球系前駆細胞の分化・増殖因子産生細胞および人顆粒球系前駆細胞の分化・増殖因子の製造法
EP0202300B1 (en) * 1984-11-20 1992-11-11 Schering Biotech Corporation Cdna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
DE3686794T2 (de) * 1985-02-05 1993-03-04 Cetus Oncology Corp Reinigung des natuerlichen kolonie-stimulierenden faktors-1.
DE3680613D1 (de) * 1985-02-08 1991-09-05 Chugai Pharmaceutical Co Ltd Menschlicher granuloxcyt-kolonie-stimulierungsfaktor.
JPH0615477B2 (ja) * 1985-02-08 1994-03-02 中外製薬株式会社 感染防禦剤
JPS63500636A (ja) * 1985-08-23 1988-03-10 麒麟麦酒株式会社 多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
DE3681551D1 (de) * 1985-09-30 1991-10-24 Chugai Pharmaceutical Co Ltd Menschlicher granulozyten-colony stimulierender faktor.
JPS6444200A (en) * 1987-08-12 1989-02-16 Kenji Hoshino Stereophonic sound field recording and reproducing system
JPH0615477A (ja) * 1992-07-02 1994-01-25 Tanaka Kikinzoku Kogyo Kk Ａｇろう

Also Published As

Publication number Publication date
FI863971L (fi) 1987-04-05
DE3683430D1 (de) 1992-02-27
AU596997B2 (en) 1990-05-24
AU6312186A (en) 1987-04-09
EP0217404A3 (en) 1988-07-13
NO863918L (no) 1987-04-06
NO863918D0 (no) 1986-10-02
ATE71662T1 (de) 1992-02-15
DK471386A (da) 1987-04-05
KR870003792A (ko) 1987-05-04
FI863971A7 (fi) 1987-04-05
EP0217404B1 (en) 1992-01-15
AU596997C (en) 1993-01-21
DK172204B1 (da) 1998-01-05
KR960000394B1 (ko) 1996-01-06
EP0217404A2 (en) 1987-04-08
FI863971A0 (fi) 1986-10-01
JPS62174026A (ja) 1987-07-30
JPH0618778B2 (ja) 1994-03-16
ES2055684T3 (es) 1994-09-01
EP0217404B2 (en) 1999-01-07
ES2055684T5 (es) 1999-06-16
HK65693A (en) 1993-07-16

Similar Documents

Publication Publication Date Title
DK471386A (da) Farmaceutisk komposition til behandling af leukopeni
ATE65798T1 (de) Menschlicher granuloxcyt-koloniestimulierungsfaktor.
LV12642A (lv) G csf analog compositions and methods
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
HUT38125A (en) Process for preparing lymphokines /cytotoxic factors/ and pharmaceutical compositions containing such active substance
ATE192500T1 (de) Rekombinante viren vektoren zur expression in muskelzellen
MY101972A (en) Primate interleukin - 4
ATE452190T1 (de) Verfahren zur isolierung und reinigung von g-csf
EP0230980A3 (en) Pharmaceutical agent for promoting the recovery of hemopoietic capacity
DE3681551D1 (de) Menschlicher granulozyten-colony stimulierender faktor.
EP0231819A3 (en) Pharmaceutical agent for the treatment of myelogenous leukemia
DE69007744D1 (de) Verwendung von Interleukin 2 zur Behandlung von Leukämien.
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
DK12990D0 (da) Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf
DE3788899D1 (de) Intraläsionale Behandlung von Basalzellenkarzinoma mittels rekombinanten humanen alpha-Interferons.
DE69306273D1 (de) Mitogen für die glatte Muskulatur und dessen kodierende DNS
ATE241698T1 (de) Hst-2 mutein, dafür kodierende dns und herstellung

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired